Seventeen saponins isolated from the root of Pulsatilla koreana were examined for their in vitro cytotoxic activity against the human solid cancer cell lines, A-549, SK-OV-3, SK-MEL-2, and HCT15, using the SRB assay method, and their in vivo antitumor activity using BDF1 mice bearing Lewis lung carcinoma (LLC). The saponins 5-17, with a free acidic functional group at C-28 of aglycon, exhibited moderate to considerable cytotoxic activity, however, the saponins 1-4, esterified with a trisaccharide at C-28 of aglycon, did not exhibit cytotoxic activity (ED 50 ; Ͼ300 m mM). Among them, oleanolic acid 3 
Pulsatilla koreana N. belongs to the family Ranunculaceae and is an endemic species in Korea. The roots of this plant have been widely used in traditional medicine for the treatment of several diseases, particular malaria and amoebic dysentery. 1) This plant has been investigated extensively, resulting in the isolation of various saponins, ranunculin, anemonin, protoanemonin and triterpenes. [2] [3] [4] Our continuing investigation of the chemical constituents of the P. koreana roots has resulted in the discovery of many saponins (Fig. 1) . 5) However, to the best of the author's knowledge, there is no report on the systematic cytotoxic and antitumor activity of the saponins isolated from the roots of this plant. The variety of their structures motivated us to examine the structure-activity relationship with the in vitro cytotoxic activity as well as the in vivo antitumor activity.
17 saponins, eight lupane-type (1, 3, 5, 7, 9, 11, 13, 15) and nine oleanane-type (2, 4, 6, 8, 10, 12, 14, 16, 17), isolated from P. koreana roots, were evaluated for their cytotoxic activity against four human solid tumor cell lines (A-549, SK-OV-3, SK-MEL-2, HCT-15). So far cytotoxic activities against tumor cell lines of these saponins have not been reported. ED 50 values obtained were reported in Table 1 . As shown in Table 1 , it was observed that the saponins 5-17, possessed free carboxylic group at C-28, exhibited moderate to considerable cytotoxic activity (ED 50 ; 1.57-174.34 mM) against tumor lines, whereas their sugar-bonded esters, that is, disdesmoside saponins 1, 2, 3, and 4 were inactive (ED 50 Ͼ300 mM). From this result, we postulate the existence of a free carboxylic group at C-28 is important for the cytotoxic activity. Among the cytotoxic saponins 5-17, oleanolic acid (14) exhibited the strongest cytotoxic activity (ED 50 ; 1.57-8.36 mM and 3.47-5.50 mM, respectively), while saponin 6 and 8, possessed hederagenin as an aglycon, exhibited weaker cytotoxic activity. From these results, we postulate the hydroxyl group at C-23 had a negative effect on the cytotoxic activity. This observation bears a striking resemble to another recent study, conducted by Barthomeuf et al. 6) This may be attributed to the electron donating effect of two lone-paired electrons of hydroxyl group toward C-3 of the aglycon (Fig. 2) . 7) In a study to determine the relationship between the structure of the sugar moiety at C-3 and the cytotoxic activity, saponins 5 and 6 possessing a trisaccharide of
]-a -L-arabinopyranosyl group, were shown to have a better cytotoxic activity than saponins 15 and 16 which had a disaccharide of the 3-O-b-D-glucopyranosyl-(1→4)-a-L-arabinopyranosyl group. This means that the presence of rhamnopyranose linked at C-2Ј of the arabinopyranosyl group enhances the cytotoxic activity of monodesmosides. In addition, it was found that there are differences in cytotoxicity between oleanane and lupane saponins. Generally, the cytotoxicities (ED 50 ; 38.14-176.34 mM) of the lupine-type saponins were much weaker than those (ED 50 ; 1.57-13.58 mM) of the oleanane-type saponins, and this result was in agreement with those reported before for similar compounds. 8) Finally, the cell specific action of the saponins was observed. Although the saponins showed no great difference in the cytotoxicity, saponins 6 and 10 exhibited a stronger cytotoxicity with ED 50 of 1.57 and 3.04 mM against the SK-MEL-2 cell line, respectively.
In order to investigate their antitumor activity, among the 17 saponins isolated from P. koreana roots, 15 saponins which could be isolated in sufficient quantities were applied for the animal test. During the period, there was no remark- Table 2 . First of all, we detected that saponins 2, 3, and 4, which contain an ester group at C-28 of aglycon, were inactive. With the exception of saponin 1, this result was coincident with the cytotoxic activity mentioned above. The straight-linked trisaccharide moiety at C-28 appeared to interrupt the activity. Among the tested saponins with a free carboxylic acid group at C-28, an oleanane-type saponin 6 had the most potent antitumor activity (IR; 66.9%), and saponin 14 (IR; 48.8%) and 17 (IR; 50.3%) also showed a good antitumor activity. On the 17th day after tumor transplantation, four tumor masses extirpated from mice which were tested by these saponins was displayed with control in Fig. 2 . All of them were more potent in the in vivo activity than Taxol ® (IR; 35.8%) used as a positive control. There was not obvious co-relationship between the in vitro cytotoxicity and the in vivo antitumor activity. For example, it is very interesting to find that saponin 10 (IR; 37.8%) having oleanolic acid as an aglycon, which showed the strongest cytotoxic activity, had an inferior in vivo antitumor activity than saponin 6 having hederagenin. It was supposed that the hederagenin structure of 6 might enhance more bioavailability to modulate cell permeablization via complexation of sterol in the plasma membrane than the oleanolic acid of 10 in the mouse tumor tissue. 9) As for the sugar moiety, saponin 6 having a-L-rhamnopyranosyl-
]-a -L-arabinopyranoside at C-3 of aglycon had a more potent activity than saponin 8 (IR; 28.0%) which had a-D-glucopyranosyl-
at the same position. Also, in case of saponin possessing straight-linked trisaccharide chain, the addition of a glucopyranoside enhanced the antitumor activity. For instance, saponin 17, produced by attaching one more glucopyranoside to C-4ٞ of glucopyranosyl moiety in saponin 8, exhibited a significant increase of 22% in the antitumor activity. In contrast, saponins 12 or 16 due to eliminating a glucopyranoside from saponin 6 reduced the antitumor activity to 20.1 and 22.8%, respectively. These results indicate that both the binding position and the number of glucopyranoside linked with the sugar sequence O-a-L-rhamnopyranosyl-(1→2)-a-L-arabinopyranoside of saponin 12 (a-hederin) play an important role in the antitumor activity. This can be explained by the rate of glucose hydrolysis in the cell. Presumably, the C-4Љ position of a-hederin than C-2Љ may be insensitive to glucose-hydrolase. Therefore the probability of reaching the active saponin to targeting site increases, suggesting that the activity is elevated. By the same token, increase in number of sugar increase the activity by declining the rate of hydrolysis, too. With regard to aglycon, saponin 5 having 23-hydroxybetulinic acid as the aglycon and the same sugar moiety as 6 had a lower antitumor activity (IR; 27.5%). The same phenomenon was observed for the pair of saponins 7 (no activity) and 8 as well as saponins 9 (IR; 6.3%) and 10. It was concluded that oleanane-type saponins showed more potent than the lupane-type saponins in vivo as well as in vitro. In conclusion, this study gave essential information of structure-activity relationship of Pulsatilla saponins for the in vitro and in vivo activities. We found that the characteristic structural features of potent antitumor saponins were to have a-L-rhamnopyranosyl-(1→2)-a-L-arabinopyranosyl group at C-3 and a free carboxylic acid at C-28 of the oleanane skeleton. At this time, the presence of hydroxyl group at C-23 of aglycon, of the third glucopyranoside attached at C-4Љ of sugar moiety, and the addition of the fourth sugar made the antitumor activity more effective in vivo.
Experimental
General Procedures Melting points were measured on an Electrothermal melting point apparatus. Optical rotations were measured using a JASCO DIP-360 automatic digital polarimeter. FAB-MS were recorded on a Extraction and Isolation The saponins 1-17 used in this study were isolated from P. koreana roots as the same method described previously. a) The antitumor activity was determined as tumor volume (T.V.) as mean value (mm 3 )ϮS.D. and inhibition rate (I.R.) as % in parentheses, in comparison with untreated control group as described on experimental section and each sample was injected at a maximum tolerate dose of 6.6 mmol/kg/d, respectively. b) Molecular weight was determined by FAB-mass spectra on a JMS-HX110/110A spectrometer. c) Each group consists of five BDF1 mice bearing Lewis lung carcinoma (LLC). Animals Male BDF1 mice, 20Ϯ2 g body weight, were purchased from SLC, Inc. (Japan), and fed commercial solid food (Samyang Yuji Co. Ltd., Seoul) and tap water. They were housed at 23Ϯ0.5°C at 60% humidity in a 12 h light-dark cycle in accordance with the guidelines for the vare and use of Laboratory Animals by Chungnam National University.
In Vitro Cytotoxicity Assay The cytotoxicity assay was carried out according to the SRB assay described previously. 10) Four human cancer cell lines, A-549 (Lung cancer), SK-OV-3 (Ovarian cancer), SK-MEL-2 (Skin cancer) and HCT-15 (Colon cancer), were examined. Doxorubicin was used as the positive control. Growth inhibition of 50% (ED 50 ) of the saponins was calculated using the method described elsewhere.
11)
In Vivo Antitumor Assay The antitumor assay on the BDF1 mice bearing Lewis lung carcinoma (LLC) cells was carried out according to the procedures described previously. 12) Each sample were then dissolved in physiological saline, and injected intraperitoneally on the 1st to 4th, 6th to 9th, and 11th to 14th day at a maximum tolerate dose of 6.6 mmol/kg, respectively. The experimental mice were weighed every day in order to evaluate the toxicity of each sample. The tumor volume (T.V.) was measured three times on the 15th and 16th day and calculated according to the following formula and taxol ® and doxorubicin were used as positive controls. 13, 14) where L and W represent the major axis and the width of the tumor mass, respectively. The inhibition ratio (I.R.) was calculated according to the following formula: 
